Literature DB >> 20599698

YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis.

David H Lovett1, Sunfa Cheng, Leslie Cape, Allan S Pollock, Peter R Mertens.   

Abstract

YB-1 is a member of the cold shock domain family, with complex roles in DNA structure, gene transcription and translation. YB-1 promotes chromosomal instability, and mammary gland transgenic expression induces tumors with 100% penetrance. YB-1 is linked to poor prognosis in breast carcinoma and is a strong predictor of relapse and disease-specific survival. Survival is directly tied to the extent of local invasion and distal metastasis, processes dependent upon the activity of the membrane type I-matrix metalloproteinase, MT1-MMP. Non-invasive MCF-7 breast adenocarcinoma cells were transfected with YB-1/EGFP. YB-1 protein was detected in the invadopodia of cells with a migratory phenotype. There was increased expression of MT1-MMP protein concentrated at the leading edges of motile cells, which were highly invasive in collagen three-dimensional culture. The rates of MT1-MMP protein endocytosis and recycling to the cell surface were elevated in clones expressing higher levels of YB-1 protein. Control MCF-7 cells formed nonfatal, non-invasive, differentiated adenocarcinomas in vivo. MCF-7 cells expressing a twofold increase in YB-1 formed highly anaplastic tumors with local invasion, pulmonary metastases and high lethality. We conclude that YB-1 contributes to the development of an invasive, metastatic breast carcinoma phenotype by enhanced presentation of MT1-MMP at the sites of cellular invasion. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599698      PMCID: PMC2925540          DOI: 10.1016/j.bbrc.2010.06.104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer.

Authors:  V Evdokimova; P Ruzanov; H Imataka; B Raught; Y Svitkin; L P Ovchinnikov; N Sonenberg
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 2.  The pleiotropic functions of the Y-box-binding protein, YB-1.

Authors:  Kimitoshi Kohno; Hiroto Izumi; Takeshi Uchiumi; Megumi Ashizuka; Michihiko Kuwano
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

3.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

4.  Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.

Authors:  P R Mertens; S Harendza; A S Pollock; D H Lovett
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

5.  Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

Authors:  D K Didier; J Schiffenbauer; S L Woulfe; M Zacheis; B D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.

Authors:  R C Bargou; K Jürchott; C Wagener; S Bergmann; S Metzner; K Bommert; M Y Mapara; K J Winzer; M Dietel; B Dörken; H D Royer
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

7.  Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation.

Authors:  J Turck; A S Pollock; L K Lee; H P Marti; D H Lovett
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

8.  Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection.

Authors:  Ute Raffetseder; Björn Frye; Thomas Rauen; Karsten Jürchott; Hans-Dieter Royer; Petra Lynen Jansen; Peter R Mertens
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

9.  Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface.

Authors:  Albert Remacle; Gillian Murphy; Christian Roghi
Journal:  J Cell Sci       Date:  2003-08-12       Impact factor: 5.285

10.  RNA-binding specificity of Y-box protein 1.

Authors:  Jinjiang Dong; Argun Akcakanat; David N Stivers; Jiexin Zhang; Doyil Kim; Funda Meric-Bernstam
Journal:  RNA Biol       Date:  2009-01-19       Impact factor: 4.652

View more
  19 in total

1.  Prognostic role of YB-1 expression in breast cancer: a meta-analysis.

Authors:  Xu Wang; Xiao-Bo Guo; Xiao-Chun Shen; Hao Zhou; Dan-Wei Wan; Xiao-Feng Xue; Ye Han; Bin Yuan; Jin Zhou; Hong Zhao; Qiao-Ming Zhi; Yu-Ting Kuang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  The role of cold shock domain proteins in inflammatory diseases.

Authors:  Jonathan A Lindquist; Sabine Brandt; Anja Bernhardt; Cheng Zhu; Peter R Mertens
Journal:  J Mol Med (Berl)       Date:  2014-02-22       Impact factor: 4.599

3.  Long noncoding RNA HOXC-AS3 indicates a poor prognosis and regulates tumorigenesis by binding to YBX1 in breast cancer.

Authors:  Jun Su; Bo Yu; Chongguo Zhang; Peiqiang Yi; Huan Li; Cheng Xu; Lu Cao; Peizhan Chen; Min Li; Kunwei Shen; Jiayi Chen
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.

Authors:  Rajeev Mahimkar; Maria Alejandra Alfonso-Jaume; Leslie M Cape; Rajvir Dahiya; David H Lovett
Journal:  Carcinogenesis       Date:  2011-09-28       Impact factor: 4.944

5.  Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1).

Authors:  San Zeng; May P Xiong
Journal:  Biomaterials       Date:  2013-06-12       Impact factor: 12.479

6.  Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.

Authors:  Qiuyang Zhang; Sen Liu; Qingsong Zhang; Zhenggang Xiong; Alun R Wang; Leann Myers; Jonathan Melamed; Wendell W Tang; Zongbing You
Journal:  Prostate       Date:  2014-04-01       Impact factor: 4.104

Review 7.  Vesicular trafficking-related proteins as the potential therapeutic target for breast cancer.

Authors:  Mohd Mughees; Himanshu Chugh; Saima Wajid
Journal:  Protoplasma       Date:  2019-12-11       Impact factor: 3.356

8.  YB-1 Is Altered in Pregnancy-Associated Disorders and Affects Trophoblast in Vitro Properties via Alternation of Multiple Molecular Traits.

Authors:  Violeta Stojanovska; Aneri Shah; Katja Woidacki; Florence Fischer; Mario Bauer; Jonathan A Lindquist; Peter R Mertens; Ana C Zenclussen
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

9.  YB-1 synthesis is regulated by mTOR signaling pathway.

Authors:  Dmitry N Lyabin; Irina A Eliseeva; Lev P Ovchinnikov
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 10.  A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.

Authors:  Akram Alkrekshi; Wei Wang; Priyanka Shailendra Rana; Vesna Markovic; Khalid Sossey-Alaoui
Journal:  Cell Signal       Date:  2021-07-03       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.